Novozymes

Novozymes is the world leader in bioinnovation. We work with our partners to innovate new solutions and rethink industries around the world. Our industrial enzymes, microorganisms, biopolymers and other proteins allow our customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. We rethink everyday products every day.
Type
Public
HQ
Bagsværd, DK
Founded
2000
Size (employees)
6,378 (est)
Novozymes was founded in 2000 and is headquartered in Bagsværd, DK

Novozymes Office Locations

Novozymes has an office in Bagsværd
Bagsværd, DK (HQ)
36 Krogshøjvej

Novozymes Data and Metrics

Novozymes Financial Metrics

USD

Market capitalization (20-Sep-2017)

15.4 b

Closing share price (20-Sep-2017)

50.8
Novozymes's current market capitalization is $15.4 b.
Show all financial metrics

Novozymes Market Value History

Traffic Overview of Novozymes

Novozymes Online and Social Media Presence

Novozymes News and Updates

UPDATE 1-Novozymes lowers 2016 guidance on weak ethanol, BioAg sales

* Novozymes posts weaker than expected second-quarter results and downgrades the full-year sales guidance due to declining sales of its ethanol enzymes and in its agriculture product alliance with Monsanto

Novozymes Company Life and Culture

You may also be interested in